These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3598600)

  • 1. Synthesis and biological activity of analogs of fecapentaene-12.
    Govindan SV; Kingston DG; Gunatilaka AA; van Tassell RL; Wilkins TD; de Wit PP; van der Steeg M; van der Gen A
    J Nat Prod; 1987; 50(1):75-83. PubMed ID: 3598600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutagenicity of synthetic racemic fecapentaene-12.
    Göggelmann W; Maier FK; Pfaendler HR
    Mutat Res; 1986 Jul; 174(3):165-7. PubMed ID: 3523232
    [No Abstract]   [Full Text] [Related]  

  • 3. The bacterial mutagenicity of synthetic all-trans fecapentaene-12 changes when assayed under anaerobic conditions.
    Venitt S; Bosworth D
    Mutagenesis; 1988 Mar; 3(2):169-73. PubMed ID: 3288841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and quantitative distribution of eight analogues of naturally occurring fecapentaenes in human feces by high-performance liquid chromatography.
    de Kok TM; ten Hoor F; Kleinjans JC
    Carcinogenesis; 1991 Feb; 12(2):199-205. PubMed ID: 1995185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electron spin resonance spectroscopy of oxygen radicals generated by synthetic fecapentaene-12 and reduction of fecapentaene mutagenicity to Salmonella typhimurium by hydroxyl radical scavenging.
    de Kok TM; van Maanen JM; Lankelma J; ten Hoor F; Kleinjans JC
    Carcinogenesis; 1992 Jul; 13(7):1249-55. PubMed ID: 1322251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fecapentaene concentration and mutagenicity in 718 North American stool samples.
    Schiffman MH; Van Tassell RL; Andrews AW; Wacholder S; Daniel J; Robinson A; Smith L; Nair PP; Wilkins TD
    Mutat Res; 1989 Apr; 222(4):351-7. PubMed ID: 2649794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genotoxicity of fecapentaene-12 in bacterial and mammalian cell assay systems.
    Curren RD; Putman DL; Yang LL; Haworth SR; Lawlor TE; Plummer SM; Harris CC
    Carcinogenesis; 1987 Feb; 8(2):349-52. PubMed ID: 3542273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case-control study of colorectal cancer and fecal mutagenicity.
    Schiffman MH; Andrews AW; Van Tassell RL; Smith L; Daniel J; Robinson A; Hoover RN; Rosenthal J; Weil R; Nair PP
    Cancer Res; 1989 Jun; 49(12):3420-4. PubMed ID: 2655896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fecapentaene excretion and fecal mutagenicity in relation to nutrient intake and fecal parameters in humans on omnivorous and vegetarian diets.
    de Kok TM; van Faassen A; Bausch-Goldbohm RA; ten Hoor F; Kleinjans JC
    Cancer Lett; 1992 Feb; 62(1):11-21. PubMed ID: 1540928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genotoxic activity of chlorinated butenoic acids in Salmonella typhimurium strains TA98, TA100 and TA104.
    Franzén R; Goto S; Tanabe K; Morita M
    Mutat Res; 1998 Sep; 417(1):31-7. PubMed ID: 9729256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effectiveness of Salmonella strains TA100, TA102 and TA104 for detecting mutagenicity of some aldehydes and peroxides.
    Dillon D; Combes R; Zeiger E
    Mutagenesis; 1998 Jan; 13(1):19-26. PubMed ID: 9491389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutagenic activities of fecapentaene derivatives in the Ames/Salmonella test system.
    Peters JH; Riccio ES; Stewart KR; Reist EJ
    Cancer Lett; 1988 Apr; 39(3):287-96. PubMed ID: 3282644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative direct-acting mutagenicity of 1- and 2-nitropyrene: evidence for 2-nitropyrene mutagenesis by both guanine and adenine adducts.
    Yu SY; Heflich RH; Von Tungeln LS; el-Bayoumy K; Kadlubar FF; Fu PP
    Mutat Res; 1991; 250(1-2):145-52. PubMed ID: 1944329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decomposition and quality control considerations in biological work with fecapentaene preparations.
    Streeter AJ; Donovan PJ; Anjo T; Ohannesian L; Sheffels PR; Wu PP; Keefer LK; Andrews AW; Bradford WW; Reist EJ
    Chem Res Toxicol; 1989; 2(3):162-8. PubMed ID: 2519720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutagenicity of different fractions of extracts of human feces.
    Dion P; Bruce WR
    Mutat Res; 1983 Feb; 119(2):151-60. PubMed ID: 6828051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fecal mutagen fecapentaene-12 damages mammalian colon epithelial DNA.
    Hinzman MJ; Novotny C; Ullah A; Shamsuddin AM
    Carcinogenesis; 1987 Oct; 8(10):1475-9. PubMed ID: 3652384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naturally occurring carbonyl compounds are mutagens in Salmonella tester strain TA104.
    Marnett LJ; Hurd HK; Hollstein MC; Levin DE; Esterbauer H; Ames BN
    Mutat Res; 1985; 148(1-2):25-34. PubMed ID: 3881660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of cytosol on mutagenesis induced by N-nitrosodimethylamine, N-nitrosomethylurea and alpha-acetoxy-N-nitrosodimethylamine in different strains of Salmonella: evidence for different ultimate mutagens from N-nitrosodimethylamine.
    Guttenplan JB
    Carcinogenesis; 1993 May; 14(5):1013-9. PubMed ID: 8504462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of dietary ascorbic acid and alpha-tocopherol on fecal mutagenicity.
    Dion PW; Bright-See EB; Smith CC; Bruce WR
    Mutat Res; 1982; 102(1):27-37. PubMed ID: 6750371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro study on the effects of fecal composition on fecapentaene kinetics in the large bowel.
    de Kok TM; van Iersel ML; ten Hoor F; Kleinjans JC
    Mutat Res; 1993 Jun; 302(2):103-8. PubMed ID: 7684504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.